Multiple sclerosis trials in Argentina

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)

  Where

  Rosario, San Miguel de Tucumán

  Age

  10 years to 17 years

  People

  12 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07161258 · EU 2024-519800-28-00
• Phase 3Taking people
  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  Where

  Buenos Aires, CABA, Rosario

  Age

  40 years to 70 years

  People

  400 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06846281 · EU 2023-509275-17-00
• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Where

  Bombal, Buenos Aires, CABA, Capital Federal, Rosario, San Juan, San Miguel de, Santiago del Estero

  Age

  18 years to 65 years

  People

  1,275 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07225504